Aerovate Therapeutics Drops 1.47% Amid Impending Jade Biosciences Merger

Mover TrackerFriday, Apr 25, 2025 6:42 pm ET

1min read

AVTE --

Aerovate Therapeutics, Inc. (AVTE) shares fell 1.47% on Thursday, marking the fourth consecutive day of decline, with a total drop of 3.25% over the past four days.

The primary factor influencing the recent fluctuations in Aerovate Therapeutics, Inc. (AVTE) stock price is the impending business combination with Jade Biosciences, Inc. This merger is anticipated to be finalized on April 28, 2025. Furthermore, Aerovate Therapeutics stockholders have given their approval for the proposed merger with Jade Biosciences.

Comments

Add a public comment...

Post

Refresh

Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.

You Can Understand News Better with AI.

Whats the News impact on stock market?

Its impact is

AInvest

Aime Coplilot

Invest Smarter With AI Power.

Open App